GlassScriptPhysician profile
Brittany Hervey
NPI 1356847537
$22,217.31
in general payments reported to CMS, 2019-2025
30 companies · $16K in 2025
The $16K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $2,072 · 2023: $2,755 · 2024: $1,450 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $5,301 · Food and Beverage: $4,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,500.00 |
| Travel and Lodging | $5,301.48 |
| Food and Beverage | $4,218.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $12,380.38 | 2023-2025 | Theragenesis Wound Matrix |
| Orthofix Medical, INC. | $3,523.96 | 2022-2025 | Truelok, Galaxy Fixation System, Truelok Evo |
| Gramercy Extremity Orthopedics LLC | $1,755.80 | 2023-2025 | |
| Treace Medical Concepts, INC. | $1,316.17 | 2022-2025 | |
| Smith+Nephew, INC. | $817.22 | 2022-2025 | Stravix, Collagenase Santyl, Grafix |
| Stryker Corporation | $711.77 | 2021-2024 | Prostep, Prophecy, Anchorage |
| International Life Sciences | $263.25 | 2023 | |
| Organogenesis INC. | $235.60 | 2023-2025 | Puraply, Cygnus Dual |
| Solventum Corporation | $223.17 | 2024-2025 | V.A.C.Ulta, Prevena, Promogran Prisma |
| Integra Lifesciences Corporation | $170.80 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Misonix INC | $113.65 | 2021 | |
| Bone Support INC. | $112.50 | 2025 | Ceramentbone Void Filler, Cerament G |
| Medline Industries LP | $77.65 | 2023-2024 | |
| Bioventus LLC | $66.19 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Convatec INC. | $64.84 | 2023-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $59.19 | 2024-2025 | Nuzyra |
| Ossio INC | $35.08 | 2023 | |
| Horizon Therapeutics Plc | $32.53 | 2022-2023 | Krystexxa |
| Medtronic, INC. | $31.17 | 2025 | Intellis Adaptivestim, Closurefast |
| Polymedics Innovations INC. | $30.13 | 2024 | |
| Sebela Pharmaceuticals INC. | $25.82 | 2023 | Naftin |
| Davol INC. | $25.49 | 2024 | Arista Ah Flexitip |
| Polynovo North America LLC | $21.96 | 2025 | Novosorb Btm |
| Next Science LLC | $21.34 | 2023 | Surgx, Blastx, Xperience |
| Dynasplint Systems INC. | $19.53 | 2024 | Dynasplint |
| Mimedx Group, INC. | $19.30 | 2024 | |
| Kci USA, INC. | $17.23 | 2023 | Activ.A.C., Promogran Prisma, 3m Coban |
| Depuy Synthes Sales INC. | $15.84 | 2025 | Healix Knotless Peek, Dynacord |
| Kowa Pharmaceuticals America, INC. | $15.74 | 2022 | |
| Reapplix INC. | $14.01 | 2025 | 3c Patch Kit - Box |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Hervey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.